Vyome Faces Competitive Landscape in Medical Supplies Industry

Analysts examine how Vyome stacks up against its publicly-traded peers in the surgical, medical, and dental instruments and supplies sector.

Published on Feb. 15, 2026

Got story updates? Submit your updates here. ›

Vyome (NASDAQ:HIND), a publicly-traded company in the 'Surgical, Medical, And Dental Instruments And Supplies' industry, was analyzed in comparison to 27 of its industry peers. The analysis looked at factors like earnings, risk, profitability, institutional ownership, dividends, analyst recommendations, and valuation to determine how Vyome measures up against the competition.

Why it matters

As a public company, Vyome's performance and positioning relative to its industry peers is an important consideration for investors and analysts tracking the medical supplies sector. This analysis provides insights into Vyome's strengths, weaknesses, and overall competitiveness within its crowded market.

The details

The analysis found that Vyome has a beta of 1.5, indicating its share price is 50% more volatile than the S&P 500, while its peers have an average beta of 1.76, meaning their share prices are 76% more volatile. In terms of net margins, return on equity, and return on assets, Vyome outperformed its peers. However, Vyome's peers had higher revenue and lower earnings per share than Vyome, though Vyome traded at a lower price-to-earnings ratio, making it more affordable. Overall, Vyome's peers outperformed it on 7 out of 13 factors compared.

  • The analysis was published on February 15, 2026.

The players

Vyome

A publicly-traded company in the 'Surgical, Medical, And Dental Instruments And Supplies' industry.

ReShape Lifesciences Inc.

A medical device company that provides products and services to manage and treat obesity and metabolic diseases.

Got photos? Submit your photos here. ›

The takeaway

This analysis highlights the competitive landscape Vyome faces as a public company in the crowded medical supplies industry. While Vyome has some strengths, such as higher profitability metrics, its peers generally outperformed it across a range of financial and operational measures. This suggests Vyome may need to further differentiate itself or improve its overall competitiveness to stand out in this market.